Search hospitals > Georgia > Atlanta
Atlanta Diabetes Associates
Claim this profileAtlanta, Georgia 30318
Global Leader in Diabetes
Global Leader in Type 1 Diabetes
Conducts research for Type 2 Diabetes
Conducts research for Cardiovascular Disease
Conducts research for Low Blood Sugar
113 reported clinical trials
2 medical researchers
Summary
Atlanta Diabetes Associates is a medical facility located in Atlanta, Georgia. This center is recognized for care of Diabetes, Type 1 Diabetes, Type 2 Diabetes, Cardiovascular Disease, Low Blood Sugar and other specialties. Atlanta Diabetes Associates is involved with conducting 113 clinical trials across 42 conditions. There are 2 research doctors associated with this hospital, such as Bruce Bode, MD and Quentin Van Meter, M.D..Top PIs
Bruce Bode, MDAtlanta Diabetes Associates1 year of reported clinical research
Studies Diabetes
Studies Type 1 Diabetes
18 reported clinical trials
27 drugs studied
Quentin Van Meter, M.D.Van Meter Pediatric Endocrinology, P.C.3 years of reported clinical research
Studies Pituitary Dwarfism
Studies Endocrine Disorders
1 reported clinical trial
1 drug studied
Clinical Trials running at Atlanta Diabetes Associates
Diabetes
Type 2 Diabetes
Cardiovascular Disease
Obesity
Type 1 Diabetes
Turner Syndrome
Syndrome
Noonan Syndrome
Small for Gestational Age, Turner Syndrome, Noonan Syndrome, Intrauterine Growth Restriction.
Central Precocious Puberty
IcoSema
for Type 2 Diabetes
This study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to insulin glargine (mentioned as insulin glargine in this form) taken daily in people with type 2 diabetes. The study will look at how well IcoSema controls blood sugar levels as compared to insulin glargine in people with type 2 diabetes who do not have their blood sugar properly controlled with other oral diabetes medicines. Participant will either get IcoSema or insulin glargine. Which treatment participants get is decided by chance. IcoSema is a new medicine that doctors cannot prescribe. Doctors can already prescribe insulin glargine in many countries. The study will last for about 11 months (47 weeks).
Recruiting2 awards Phase 3
MiniMedâ„¢ 780G System
for Type 2 Diabetes
The objective of the study is to assess the safety and effectiveness of MiniMedâ„¢ 780G system in adult subjects with insulin-requiring type 2 diabetes in a home setting. The combined run-in period and study period will be approximately 135 days long.
Recruiting1 award N/A3 criteria
Eversense CGM
for Diabetes
This study is evaluating whether a continuous glucose monitor may help people with diabetes better manage their blood sugar.
Recruiting1 award N/A5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Atlanta Diabetes Associates?
Atlanta Diabetes Associates is a medical facility located in Atlanta, Georgia. This center is recognized for care of Diabetes, Type 1 Diabetes, Type 2 Diabetes, Cardiovascular Disease, Low Blood Sugar and other specialties. Atlanta Diabetes Associates is involved with conducting 113 clinical trials across 42 conditions. There are 2 research doctors associated with this hospital, such as Bruce Bode, MD and Quentin Van Meter, M.D..